Biotech

All Articles

AZ licenses discarded uncommon condition medication to Monopar Therapies

.Monopar Therapies is recuperating a drug coming from the scrap heap of AstraZeneca's unusual health...

Arcus' brand new HIF-2a data in renal cancer cells hint at potential upper hand over Merck's Welireg, analysts point out

.With new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of professionals...

Roche wagers as much as $1B to extend Dyno gene treatment delivery contract

.After developing a genetics therapy alliance along with Dyno Rehabs in 2020, Roche is actually back...

Lundbeck slashes value of $250M Abide acquistion after discomfort problem

.Lundbeck is actually reducing the book value of its $250 thousand Abide Therapeutics acquistion in ...

Real- Planet Data Complies With Medical Test Layout: Optimizing Methods as well as Web Site Variety

.The combination of real-world records (RWD) into protocol workability and website option has become...

Where are they now? Overtaking previous Tough 15 guest of honors

.At this year's Intense Biotech Summit in Boston, our company caught up with leaders in the biotech ...

Merck grabs preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is setting down $30 million in advance to buy Yale spinout Modifi Biosciences, an of...

Radiopharma Alpha-9 increases $175M collection C to finance scientific push

.Alpha-9 Oncology has actually raised a $175 thousand set C round to stake its clinical-stage radiop...

Ocuphire to change right into gene therapy biotech using Opus purchase

.Eye medicine creator Ocuphire Pharma is acquiring gene therapy creator Piece Genes in an all-stock ...

Roche culls cough applicant, pivots KRAS program in Q3 upgrade

.Roche's severe cough plan has faltered to a standstill. The drugmaker, which axed the program after...